Takeda Ventures

Takeda Ventures

$100,000,000 Venture capital (Series B)
FinSMEs

Palleon Pharmaceuticals Raises $100M in Series B Funding

$137,000,000 Venture capital (Series B)
Xconomy , FinSMEs

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

$45,000,000 Venture capital (Series B)
Xconomy

Cerevance Raises $45M to Advance Brain Disease Research & Development

$100,500,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Xilio Therapeutics Raises $100.5M in Series B Financing

PE HUB

Hookipa Pharma debuts IPO

$37,400,000 Venture capital (Series D)
FinSMEs

Hookipa Pharma Raises $37.4M in Series D Financing

$65,000,000 Venture capital (Series B)
PE HUB

Ribon Therapeutics lands $65 mln Series B

$30,000,000 Venture capital (Series A)
FinSMEs , PE HUB , MedCity News , +1

Akrevia Therapeutics Raises $30M in Series A Financing

Funding Health
$140,000,000 Venture capital (Series A)
FinSMEs

Ambys Medicines Launches with $140M in Funding

Health Science Funding
$15,700,000 Venture capital (Series A)
Venture Funding News , PE HUB

StrideBio Closes $15.7M Series A

FinSMEs

StrideBio Closes $15.7M in Series A Financing

Funding
$76,000,000 Venture capital (Series B)
FinSMEs , PE HUB , MedCity News

Cortexyme Completes $76M in Series B Financing

Funding Health
$59,600,000 Venture capital (Series C)
PE HUB

| Hookipa Biotech scores $59.6 mln Series C

PE HUB

| VC-backed Outpost Medicine hires chief medical officer

Health Funding
$20,000,000 Venture capital (Series A)
PE HUB

Outpost Medicine rakes in $20 mln

$48,000,000 Venture capital (Series A)
Xconomy

Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug

Health Science Funding
Xconomy

Ultragenyx Sweetens Offer, Dimension Tx Agrees to $151M Acquisition

Health Strategy
$36,000,000 Venture capital (Series A)
takeda

CEREVANCE LAUNCHED WITH NEW TECHNOLOGY, DRUG PORTFOLIO AND $36M IN CASH TO TACKLE BRAIN DISEASES Pharmaceutical Company...

$13,000,000 Venture capital (Series A)
socalTECH.com , sec

Bioniz Therapeutics Raises $13M In Funding Round

Funding Health
$65,000,000 Post-IPO equity
FierceBiotech

Ultragenyx picks up $65M investment, asset in Takeda rare disease R&D pact

Health Deals